Abstract 1487P
Background
Information and Communication Technology-based self-management support has been demonstrated to be effective in relieving symptoms for patients with advanced cancer. This study aimed to evaluate the effectiveness of a telemonitoring system for cancer pain relief in outpatients with advanced cancer in Japan.
Methods
The study was conducted between December 2019 and February 2023. This study included patients attending Tohoku University Hospital as outpatients, regularly taking opioids for cancer pain, with a mean pain NRS of ≥3 in 24 hours. Participants were randomized into intervention and control groups in a 1:1 ratio. The intervention group received telemonitoring care using the Cancer Pain Monitoring System (CAPAMOS). This comprises five components: symptom checks, medication checks, graphical records, pain booklet, and contact with a telenurse (chats, phones, and video phones). Alerts were sent to a telenurse when a patient’s symptoms worsened. The control group maintained a pain diary. An assessment of pain (NRS), quality of life (VAS), and opioid self-management scale (Opioid Self-Management Scale for Advanced Cancer Patients with Pain: OSSA) was conducted at baseline and after 2 and 4 weeks. Further, the Ethics Committee of Tohoku University Graduate School of Medicine reviewed the study (approval no. 2020-1-194).
Results
A total of 48 patients were enrolled in this study. There were no significant differences in baseline age (intervention 53.5 vs. control 57.0, p=0.68), severe pain (5.0 vs. 5.0, p=0.92), average pain (4.0 vs. 4.0, p=0.41), OSSA scores (135.0 vs. 130.0, p=0.06) and QOL (70.0 vs. 64.0, p=0.86) between groups. At 2 weeks post-intervention, no significant association was observed. At 1 month post-intervention, severe pain (5.0 vs. 5.5, p = 0.37), average pain (3.0, vs. 4.0, p = 0.41), OSSA scores (136.5 vs. 123.5, p=0.06), and QOL scores (57.5 vs. 50.0, p = 0.58) were not statistically significant. The scores for understanding pain characteristics in OSSA were significantly higher in the OSSA group than in the control group (10.0 vs. 8.0, p=0.04).
Conclusions
Telemonitoring support has led to educational advantages, such as improving patients’ understanding of opioid self-management and pain characteristics.
Clinical trial identification
UMIN000038334.
Editorial acknowledgement
Legal entity responsible for the study
Tohoku University Graduate School of Medicine.
Funding
JSPS KAKENHI.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1199P - Developing and systematically validating homologous recombination repair gene detection method based on next-generation sequencing
Presenter: Yi Sun
Session: Poster session 10
1200P - Investigation of multiphoton microscopy as an innovative tool for intraoperative section-free histologic investigations in just a few minutes
Presenter: Martí Homs Soler
Session: Poster session 10
1201P - Novel deep learning model and validation of whole slide images in lung cancer diagnosis
Presenter: Alhassan Ahmed
Session: Poster session 10
Resources:
Abstract
1202P - A deep learning approach using routine pathology images to guide precision medicine in metastatic CRC
Presenter: Chaitanya Parmar
Session: Poster session 10
1203P - Analytical evaluation of whole genome sequencing for acute myeloid leukemia
Presenter: Guidantonio Malagoli Tagliazucchi
Session: Poster session 10
1204P - Real-world utility of whole genome sequencing for patients with cancer: Evaluation of a regional implementation of the 100,000 genomes project
Presenter: Helen Robbins
Session: Poster session 10
1205P - A retrospective machine learning-based analysis of nationwide cancer CGP data across cancer types to identify features associated with recommendation of mutation-based therapy
Presenter: Hiroaki Ikushima
Session: Poster session 10
1478P - Dual single-nucleotide polymorphism biomarker combination to select opioid for cancer pain management
Presenter: Yoshihiko Fujita
Session: Poster session 10
1479P - Use of rescue opioids and pain control after ketamine initiation in refractory cancer pain: A multicentric observational study
Presenter: Pablo Gallardo Melo
Session: Poster session 10
1480P - Long term therapy with denosumab and zoledronic acid: A comparative real-world retrospective observational study on skeletal-related events and pain in patients with metastatic breast cancer
Presenter: Giacomo Massa
Session: Poster session 10